Defining a Safe Biopsy Deferral Strategy in Patients With Low‐Risk or Equivocal MRI Findings Using Prostate‐Specific Antigen‐Based Metrics
Omer Tarik Esengur,
Stephanie A. Harmon,
Emma J. Stevenson,
Rikhil D. Makwana,
Donald C. Wunsch III,
Maria J. Merino,
Sandeep Gurram,
Peter L. Choyke,
Peter A. Pinto,
Baris Turkbey
Wiley ·
2026-11-14
· DOI 10.1002/pros.70243
The publisher did not provide an abstract — full text is available via the link below.
Omer Tarik Esengur, Stephanie A. Harmon, Emma J. Stevenson, Rikhil D. Makwana, Donald C. Wunsch III, Maria J. Merino et al. Defining a Safe Biopsy Deferral Strategy in Patients With Low‐Risk or Equivocal MRI Findings Using Prostate‐Specific Antigen‐Based Metrics. // Prostate. – 2026. – DOI: 10.1002/pros.70243. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pros.70243?af=R
Omer Tarik Esengur, Stephanie A. Harmon, Emma J. Stevenson, Rikhil D. Makwana, Donald C. Wunsch III, Maria J. Merino, Sandeep Gurram, Peter L. Choyke, Peter A. Pinto, & Baris Turkbey (2026). Defining a Safe Biopsy Deferral Strategy in Patients With Low‐Risk or Equivocal MRI Findings Using Prostate‐Specific Antigen‐Based Metrics. Prostate. https://doi.org/10.1002/pros.70243
Omer Tarik Esengur, et al. “Defining a Safe Biopsy Deferral Strategy in Patients With Low‐Risk or Equivocal MRI Findings Using Prostate‐Specific Antigen‐Based Metrics.” Prostate, 2026. doi:10.1002/pros.70243.
@article{Esengur2026,
title = {Defining a Safe Biopsy Deferral Strategy in Patients With Low‐Risk or Equivocal MRI Findings Using Prostate‐Specific Antigen‐Based Metrics},
author = {Esengur, Omer Tarik and Harmon, Stephanie A. and Stevenson, Emma J. and Makwana, Rikhil D. and III, Donald C. Wunsch and Merino, Maria J. and Gurram, Sandeep and Choyke, Peter L. and Pinto, Peter A. and Turkbey, Baris},
journal = {Prostate},
year = {2026},
doi = {10.1002/pros.70243},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pros.70243?af=R}
}